Dr. Robert A. Kloner reviews medical content for Healthwise, a
nonprofit organization with a mission to help people make better health
decisions. Dr. Kloner is a Professor of Medicine in the Cardiovascular
Division, Keck School of Medicine, at the University of Southern California in
Los Angeles. He is also Director of Research at the Heart Institute of Good
Samaritan Hospital in Los Angeles and attending cardiologist at Los Angeles
County/University of Southern California Medical Center.
Among Dr. Kloner's major research interests are cardiac cell
transplantation, protection of ischemic myocardium, development of therapies
for limiting myocardial infarct size, cardiac function following coronary
artery occlusion, the effect of toxins on the heart, preventive cardiology,
hypertension, and PDE5 inhibition. He is currently participating in studies
funded by the National Institutes of Health on cardiac cell transplantation,
doxorubicin cardiomyopathy, functional analysis of cardiac grafts, and stem
cells. He has served on the NIH Cardiovascular Study Section A and has
participated in a number of NIH Workshops.
A frequent contributor to the medical and scientific press, Dr.
Kloner has contributed more than 530 original papers, over 205 chapters or
monographs, and more than 430 abstracts. Dr. Kloner is the author and editor of
18 medical texts including: Cardiovascular Trials Reviews (10 editions), Guide to Cardiology,
Stunned Myocardium, Ischemic Preconditioning, VIAGRA, and Heart Disease and Erectile Dysfunction. He is also the author
of three novels: The Beta Virus, Mind Cure, and The Deity Genes.
Among his editorial responsibilities, Dr. Kloner serves as associate
editor of the Journal of Cardiovascular Pharmacology and Therapeutics and the International Journal of Impotence Research, and is on the editorial boards of Circulation, American Journal of Cardiology, Heart, Basic Research in Cardiology, and Regenerative Medicine. Among
his many career distinctions, Dr. Kloner has been listed in Who's Who in America and Best Doctors in America and in 2002 was identified by the Institute for Scientific
Information as one of the world's most highly cited scientific authors.
Board Certifications
American Board of Internal
Medicine-1978
American Board of Internal Medicine, Cardiovascular
Diseases-1981
Healthwise Knowledgebase Topics Reviewed
Congestive Heart Failure
Coronary
Artery Disease
Dilated Cardiomyopathy, Hypertrophic Cardiomyopathy,
and Restrictive Cardiomyopathy
Hypertension
Mitral
Valve Prolapse
Pericarditis and Endocarditis
Education
BS: Northwestern University Honors Program in
Medical Education, 1971
PhD: Northwestern University,
1974
MD: Northwestern University Medical School,
1975
Internships and Residencies:
Peter Bent Brigham Hospital:
Medical House Officer,
1975-1976
Assistant Resident Physician,
1976-1977
Senior Resident Physician, 1977-1978
Harvard Medical School:
Clinical Fellow in Medicine,
1975-1978
Research Fellowship in Medicine, Harvard
Medical School, 1978-1979
Research/Clinical Fellowship in Medicine
(Cardiology), Peter Bent Brigham Hospital, 1978-1979
Academic Appointments
Harvard Medical School:
Assistant Professor of Medicine,
1979-1984
Associate Professor of Medicine, 1984
Wayne State University School of Medicine,
Professor of Internal Medicine, 1985-1988
University of Southern
California School of Medicine, Professor of Medicine, 1988-present
Hospital Affiliations
Brigham and Women's Hospital:
Junior Associate in Medicine,
1979-1982
Associate Physician, 1982-1984
Director of Cardiac Research Laboratory,
Harvard Medical School, 1979-1984
Director of Myocardial Ischemia
Laboratory, Wayne State University School of Medicine,
1985-1988
Director of Research, The Heart
Institute of Good Samaritan Hospital, Los Angeles,
1988-present
Attending Cardiologist, Los Angeles County/University
of Southern California Medical Center, 1988-present
Professional Affiliations
American College of
Cardiology
American Heart Association, Council on Clinical
Cardiology
American Society for Clinical
Investigation
International Society of Heart Research
Selected Publications
Dai W, Kloner RA (2007). Myocardial
regeneration by human amniotic fluid stem cells: Challenges to be overcome.
Journal of Molecular and Cellular Cardiology, 42(4):
730-732.
Kloner RA (2006). Natural and unnatural triggers of
myocardial infarction. Progress in Cardiovascular Diseases, 48(4): 285-300.
Reffelmann T, Kloner RA (2006).
Cardiovascular effects of phosphodiesterase 5 inhibitors. Current Pharmaceutical Design, 12(27): 3485-3494.
Kloner RA, Dow J, Bhandari A. (2006) Postconditionining markedly
attenuates ventricular arrhythmias following ischemia/reperfusion.
Journal of Cardiovascular Pharmacology and Therapeutics,
11(1): 55-63.
Kloner RA (2006). Can we trigger an acute coronary
syndrome? Heart, 92(8):1 009-1010.
Financial Disclosure
Dr. Kloner is a speaker and consultant for Pfizer and Lilly, is a
speaker for Novartis, and speaks and has a research grant from CV
Therapeutics.
